Koichi Node Selected Research

Koichi Node Research Topics

Disease

69	Heart Failure 04/2024 - 07/2003
64	Type 2 Diabetes Mellitus (MODY) 02/2024 - 05/2005
48	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2003
31	Hypertension (High Blood Pressure) 04/2024 - 12/2006
28	Myocardial Infarction 04/2024 - 01/2002
28	Inflammation (Inflammations) 12/2022 - 10/2004
26	Atherosclerosis 01/2024 - 08/2006
24	Chronic Renal Insufficiency 02/2024 - 01/2006
21	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 05/2003
17	Diabetes Mellitus 01/2023 - 08/2007
15	Stroke (Strokes) 04/2024 - 08/2007
14	Insulin Resistance 01/2023 - 05/2005
13	Body Weight (Weight, Body) 06/2023 - 09/2002
12	Infarction (Infarctions) 01/2019 - 01/2002
11	Hyperuricemia 01/2024 - 06/2016
11	Carotid Artery Diseases 11/2023 - 01/2012
11	Proteinuria 01/2023 - 05/2008
10	Thrombosis (Thrombus) 11/2022 - 04/2009
10	Dyslipidemias (Dyslipidemia) 10/2021 - 02/2010
9	Atrial Fibrillation 04/2024 - 11/2006
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2024 - 09/2006
9	Fibrosis (Cirrhosis) 06/2023 - 03/2008
9	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2023 - 08/2003
9	Ischemia 10/2016 - 01/2002
8	Neoplasms (Cancer) 04/2024 - 04/2008
8	COVID-19 03/2024 - 10/2020
8	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 05/2002
7	Obesity 07/2022 - 10/2009
7	Acute Coronary Syndrome 01/2021 - 05/2013
7	Hypertrophy 01/2019 - 09/2002
7	Cardiomegaly (Heart Hypertrophy) 09/2017 - 01/2002
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 03/2006
6	Coronary Occlusion 12/2004 - 01/2002
6	Reperfusion Injury 10/2004 - 01/2002
5	Angina Pectoris 04/2024 - 01/2022
5	Prediabetic State (Prediabetes) 03/2023 - 01/2022
5	Hyperemia 11/2020 - 12/2008
5	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2017 - 08/2008
5	Hyperglycemia 01/2014 - 11/2006
4	ST Elevation Myocardial Infarction 07/2022 - 11/2014
4	Hemorrhage 04/2022 - 01/2009
4	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 11/2007
4	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 01/2014
4	Vascular System Injuries 11/2011 - 06/2008

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 11/2006
26	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2016
26	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 08/2003
24	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2006
17	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2017
14	empagliflozinIBA 03/2023 - 04/2016
14	CanagliflozinIBA 01/2023 - 04/2016
14	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 06/2014
13	LipidsIBA 10/2022 - 06/2007
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2002
12	CholesterolIBA 03/2024 - 08/2003
12	SodiumIBA 02/2024 - 01/2018
12	Uric Acid (Urate)IBA 11/2023 - 05/2007
11	Hypoglycemic Agents (Hypoglycemics)IBA 03/2023 - 08/2011
10	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2024 - 01/2016
10	LDL CholesterolIBA 11/2023 - 02/2010
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2009
9	HDL CholesterolIBA 03/2024 - 07/2006
9	ipragliflozinIBA 02/2024 - 01/2016
9	Insulin (Novolin)FDA Link 01/2023 - 11/2006
9	CreatinineIBA 01/2020 - 07/2006
9	Angiotensin IIIBA 01/2018 - 08/2006
8	Febuxostat FDA Link 01/2024 - 06/2016
8	oxidized low density lipoproteinIBA 06/2023 - 05/2006
8	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 08/2015
8	anagliptinIBA 01/2022 - 01/2018
8	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2011
8	Fatty Acid-Binding ProteinsIBA 01/2020 - 01/2006
8	CytokinesIBA 03/2014 - 03/2008
7	Antihypertensive Agents (Antihypertensives)IBA 04/2024 - 08/2011
7	Triglycerides (Triacylglycerol)IBA 03/2024 - 07/2006
7	C-Reactive ProteinIBA 09/2022 - 07/2005
7	Angiotensin Receptor AntagonistsIBA 10/2017 - 10/2008
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2009 - 01/2002
6	glimepiride (Amarel)FDA LinkGeneric 01/2023 - 01/2014
6	AdiponectinIBA 08/2013 - 07/2006
5	Serum AlbuminIBA 04/2024 - 01/2010
5	SymportersIBA 02/2024 - 01/2018
5	Xanthine OxidaseIBA 01/2024 - 06/2016
5	AlbuminsIBA 01/2022 - 11/2007
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 05/2006
5	IncretinsIBA 11/2019 - 05/2011
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2018 - 04/2003
5	Hormones (Hormone)IBA 09/2017 - 07/2003
5	EnzymesIBA 01/2017 - 07/2006
5	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2003 - 01/2002
4	omega-Chloroacetophenone (Mace)IBA 05/2023 - 12/2018
4	SaltsIBA 01/2023 - 05/2012
4	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2002
4	pitavastatin (itavastatin)FDA Link 01/2013 - 10/2004

Therapy/Procedure

52	Therapeutics 01/2024 - 01/2002
12	Stents 04/2022 - 05/2004
11	Percutaneous Coronary Intervention 07/2022 - 01/2004
8	Glycemic Control 01/2021 - 01/2014
6	Drug Therapy (Chemotherapy) 04/2024 - 11/2014
4	Exercise Therapy (Therapy, Exercise) 01/2020 - 02/2010